The White House announced the creation of ARPA-H, the Advanced Research Projects Agency for Health. ARPAH is proposed to stand as a bold research initiative housed under the National Institute of Health (NIH) though set apart by its distinct research style to achieve health breakthrough. The Chicago-area and the state of Illinois compete with traditional life science hubs to root ARPA-H at the core of America’s heartland. As the Gateway to the Midwest Innovation, stakeholders across the Chicago region and the state of Illinois are collaborating to pitch Chicago as the location for ARPA-H. The official announcement to bring ARPA-H to Illinois was published in a delegation letter on June 30th, 2022.
The delegation letter outlines why the Chicago region would help the agency fulfill its mission. The basis of the bid include:
World Business Chicago is working with other stakeholders to amplify the call to bring ARPA-H to the Chicago region. The campaign is led via social media using digital touchpoints. The case for Chicago is best made through your contributions as key players in the life sciences ecosystem.
As a funder in life science research, Walder Foundation knows the innovation and vision of Chicago scientists and research institutions. The multidisciplinary excellence, combined with a commitment to collaboration and health equity in its work, makes Chicago an ideal partner for ARPA-H. Together we can unlock true breakthroughs in health that benefit all people.
Use the relevant hashtags (#Chicago_ARPAH and #ARPAH) and assets linked here. Talk about how great a fit Chicago is to this potential opportunity. Help us show ARPA-H decision makers why Chicagoland is the perfect location for ARPA-H. If you have strong connections with any media who could be pitched to report on this effort to promote, support, and help this news travel far and wide, please reach out.
The University of Illinois Chicago (UIC) is Chicago’s largest and only public research institution with an academic health system focused on health equity and community engagement. As a collaborative hub, UIC is impacting education, innovation and sponsored research for the transformation of Chicago, and will be a ready ARPA-H partner in continuing to drive life-changing health breakthroughs.
Use the relevant hashtags (#Chicago_ARPAH and #ARPAH) and share the assets below.
Talk about how great a fit Chicago is to this potential opportunity. Help us show ARPA-H decision makers why Chicagoland is the perfect location for ARPA-H.
Aligned completely with ARPA-H’s mission, the Chicago Biomedical Consortium finds and funds biomedical research from UChicago, Northwestern, and UIC that will become breakthrough medicines. Because we live this every day, connecting Chicago’s best scientific ideas to the clinical and technical capabilities that produce therapeutic realities, we know that ARPA-H will thrive here in Chicago.